Franklin Genomic Advancements ETF
HELX
8 hedge funds and large institutions have $2.21M invested in Franklin Genomic Advancements ETF in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
2.48% less ownership
Funds ownership: 22.9% → 20.42% (-2.5%)
26% less capital invested
Capital invested by funds: $2.97M → $2.21M (-$767K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.12M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$77.4K |
| 3 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$49.6K |
| 4 |
LPL Financial
San Diego,
California
|
+$26K |
| 5 |
HHGA
Halbert Hargrove Global Advisors
Long Beach,
California
|
+$22.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$970K |
| 2 |
GT
Glenview Trust
Louisville,
Kentucky
|
-$941K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $1.25M | +$1.12M | +38,153 | +479% |
|
|
2
LPL Financial
San Diego,
California
| $482K | +$26K | +885 | +5% |
|
|
3
Jane Street
New York
| $217K | -$970K | -32,981 | -80% |
|
4
UBS Group
Zurich,
Switzerland
| $71.9K | +$16K | +544 | +26% |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $71K | +$77.4K | +2,630 | New |
|
|
HHGA
6
Halbert Hargrove Global Advisors
Long Beach,
California
| $69K | +$22.2K | +753 | +42% |
|
|
HI
7
Harbour Investments
Madison,
Wisconsin
| $49.2K | +$49.6K | +1,687 | +1,240% |
|
8
Morgan Stanley
New York
| $33 | +$29 | +1 | New |
|
9
JP Morgan Chase
New York
| $1 | – | – | – |
|
|
GT
10
Glenview Trust
Louisville,
Kentucky
| – | -$941K | -32,625 | Closed |
|
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$12K | -400 | Closed |
|
HELX Hedge Fund Activity: Q1 2025 in Review
8 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Franklin Genomic Advancements ETF (HELX) for Q1 2025, worth a combined $2.21M — down 26% from $2.97M a quarter earlier.
Fund positioning in HELX was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $1.12M. The largest seller was Jane Street, cutting an estimated $970K.
- 8 institutional investors held Franklin Genomic Advancements ETF (HELX) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $2.21M of Franklin Genomic Advancements ETF stock for Q1 2025, down 26% quarter-over-quarter.
- 2 funds opened new Franklin Genomic Advancements ETF positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest Franklin Genomic Advancements ETF buyer in Q1 2025 was Citadel Advisors, an estimated $1.12M added.
- The largest Franklin Genomic Advancements ETF seller in Q1 2025 was Jane Street, an estimated $970K sold.
Based on aggregated 13F filings for Q1 2025.